The Pathology Core (Core D) will perform all microscopic analyses needed for the four Projects of this PPG. The Core has state-of-the-art facilities and extensive experiences with virtually all pathologic analyses of cardiac tissues. This Core represents the continuation of the ongoing collaboration between Dr. Anversa's team at the New York Medical College and the Cardiology team at the University of Louisville, which have worked together for the past two years. The logistics of this arrangement have been extensively tested, and do not pose any problem. Following perfusion fixation, tissue samples will be obtained in each of the four Projects
at the University of Louisville and sent to the Pathology Core at New York Medical College for analysis. The Core will perform several functions that can be summarized as follows. 1. Morphometric analysis of infarct size, myocyte volume and number, and length density of resistance arterioles and capillary network within the myocardium. Myocyte volume will be assessed both in situ and in enzymatically dissociated cells. Myocyte classes and distribution will be analyzed with confocal microscopy both in situ and in isolated myocytes. These
measurements will enable us to calculate the total number of myocytes lost during post-infarction LV remodeling (Project 2) and to compare the number of lost myocytes with conventional measurements of infarct size by tetrazolium staining at 24 h of reperfusion. 2. Two-photon microscopy to perform simultaneous detection of multiple antigens without the limitations imposed by photobleaching of fluorophores. Two-photon microscopy will also be used to measure pyridine nucleotides in Project 4. 3. Confocal microscopic analysis of tissue
sections obtained from perfusion-fixed hearts. The combination of two-photon and confocal microscopy will enable us to quantitate the expression of multiple antigens (e.g., iNOS, HO-1, ecSOD, nitrotyrosines, protein-HNE adducts, protein-MDA adducts, protein carbonyls) simultaneously in the same tissue section. Two-photon and confocal microscopy will be employed for quantitative analysis of fluorescence intensity of iNOS, HO-1, ecSOD, protein-HNE adducts, protein-MDA adducts, nitrotyrosines, and 8-hydroxy-deoxyguanosine. All
immunocytochemistry will be done by using primary antibodies labeled directly with the fluorochromes recognized by our two-photon microscope and confocal microscope, which will avoid the complications of nonspecific staining and cross-reactivity between antibodies. 4. Quantitative measurement of apoptotic and necrotic cells with our newly-developed dual-labeling technique (hairpin-1 in situ ligation coupled with immunohistochemistry for active caspase-3, hairpin-2 ligation coupled with immunohistochemistry for active caspase-3), along with TUNEL. The dual hairpin-1/active caspase-3 labeling and hairpin-2/active caspase-3 labeling will afford a very high degree of specificity in assigning a cell to apoptosis vs. necrosis. 5. Routine
histologic examination to assess inflammation, fibrosis, or any other morphologic changes.
No Sub Projects information available for 5P01HL078825-03 9003
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01HL078825-03 9003
Patents
No Patents information available for 5P01HL078825-03 9003
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01HL078825-03 9003
Clinical Studies
No Clinical Studies information available for 5P01HL078825-03 9003
News and More
Related News Releases
No news release information available for 5P01HL078825-03 9003
History
No Historical information available for 5P01HL078825-03 9003
Similar Projects
No Similar Projects information available for 5P01HL078825-03 9003